The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation - A single-centre experience

Canadian Journal of Gastroenterology

Volumn 24, Issue 1, 2010, Pages 40-46

  Moncrief, Karli J ^a   Savu, Anamaria ^a   Ma, Mang M ^a   Bain, Vince G ^a   Wong, Winnie W ^a   Tandon, Puneeta ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Inflammatory bowel disease; Liver transplantation; Primary sclerosing cholangitis; PSC; Recurrent PSC

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; COLON RESECTION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG DOSE REDUCTION; ENTERITIS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

EID: 77951236518     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/830291     Document Type: Article

References (44)

1. Gordon RD, Shaw BW Jr, Iwatsuki S, et al. Indications for liver transplantation in the cyclosporine era. Surg Clin North Am 1986;66:541-556 (Pubitemid 16057677)
2. Talwalkar JA, Lindor KD. Primary sclerosing cholangitis. Inflamm Bowel Dis 2005;11:62-72.
3. Portincasa P, Vacca M, Moschetta A, et al. Primary sclerosing cholangitis: Updates in diagnosis and therapy. World J Gastroenterol 2005;11:7-16. (Pubitemid 40090127)
4. Vacca M, Krawczyk M, Petruzzelli M, et al. Current treatments of primary sclerosing cholangitis. Curr Med Chem 2007;14:2081-2094 (Pubitemid 47578165)
5. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997;225:472-81;discussion 481-483 (Pubitemid 27123496)
6. Bjoro K, Brandsaeter B, Foss A, et al. Liver transplantation in primary sclerosing cholangitis. Semin Liver Dis 2006;26:69-79. (Pubitemid 43320729)
7. Saldeen K, Friman S, Olausson M, et al. Follow-up after liver transplantation for primary sclerosing cholangitis: Effects on survival, quality of life, and colitis. Scand J Gastroenterol 1999;34:535-540 (Pubitemid 29307827)
8. Khuroo MS, Al Ashgar H, Khuroo NS, et al. Biliary disease after liver transplantation: The experience of the King Faisal Specialist Hospital and Research Center, Riyadh. J Gastroenterol Hepatol 2005;20:217-228
9. Sheng R, Campbell WL, Zajko AB, et al. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: Evidence of recurrent disease. Am J Roentgenol 1996;166:1109-1113 (Pubitemid 26122956)
10. Graziadei IW, Wiesner RH, Batts KP, et al. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999;29:1050-1056 (Pubitemid 29168735)
11. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997;25:658-663
12. Befeler AS, Lissoos TW, Schiano TD, et al. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation 1998;65:393-396 (Pubitemid 28095969)
13. Lucidi V, Lemye AC, Baire L, et al. Use of marginal donors for liver transplantation: A single-center experience within the Eurotransplant patient-driven allocation system. Transplant Proc 2007;39:2668-2671 (Pubitemid 47588370)
14. Silberhumer GR, Pokorny H, Hetz H, et al. Combination of extended donor criteria and changes in the model for end-stage liver disease score predict patient survival and primary dysfunction in liver transplantation: A retrospective analysis. Transplantation 2007;83:588-592 (Pubitemid 46440248)
15. Schemmer P, Nickkholgh A, Hinz U, et al. Extended donor criteria have no negative impact on early outcome after liver transplantation: A single-center multivariate analysis. Transplant Proc 2007;39:529-534 (Pubitemid 46386206)
16. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford: Oxford Science Publications, 1993.
17. Agresti A. Categorical Data Analysis. New York: John Wiley & Sons, 1990.
18. Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 1989;10:430-436
19. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-615 (Pubitemid 26111384)
20. Okolicsanyi L, Fabris L, Viaggi S, et al. Primary sclerosing cholangitis. Clinical presentation, natural history and prognostic variables: An Italian multicentre study. The Italian PSC study group. Eur J Gastroenterol Hepatol 1996;8:685-691 (Pubitemid 26241599)
21. Papatheodoridis GV, Hamilton M, Mistry PK, et al. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut 1998;43:639-644 (Pubitemid 28520097)
22. van de Vrie W, de Man RA, van Buuren HR, et al. Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2003;15:657-663 (Pubitemid 36688231)
23. Dvorchik I, Subotin M, Demetris AJ, et al. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology 2002;35:380-384 (Pubitemid 34106378)
24. Ho GT, Seddon AJ, Therapondos G, et al. The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: Further appraisal of immunosuppression post transplantation. Eur J Gastroenterol Hepatol 2005;17:1379-1385 (Pubitemid 41830461)
25. Haagsma EB, Van Den Berg AP, Kleibeuker JH, et al. Inflammatory bowel disease after liver transplantation: The effect of different immunosuppressive regimens. Aliment Pharmacol Ther 2003;18:33-44. (Pubitemid 36897979)
26. Gavaler JS, Delemos B, Belle SH, et al. Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis. Dig Dis Sci 1991;36:321-328
27. Shaked A, Colonna JO, Goldstein L, et al. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 1992;215:598-603. Discussion 604-605
28. Miki C, Harrison JD, Gunson BK, et al. Inflammatory bowel disease in primary sclerosing cholangitis: An analysis of patients undergoing liver transplantation. Br J Surg 1995;82:1114-1117
29. Gow PJ, Chapman RW. Liver transplantation for primary sclerosing cholangitis. Liver 2000;20:97-103. (Pubitemid 30219134)
30. Graziadei IW, Wiesner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999;30:1121-1127 (Pubitemid 29510847)
31. Vera A, Moledina S, Gunson B, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002;360:1943-1944 (Pubitemid 35472138)
32. Alexander J, Lord JD, Yeh MM, et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008;14:245-251 (Pubitemid 351267284)
33. Campsen J, Zimmerman MA, Trotter JF, et al. Clinically recurrent primary sclerosing cholangitis following liver transplantation: A time course. Liver Transpl 2008;14:181-185 (Pubitemid 351267274)
34. Cholongitas E, Shusang V, Papatheodoridis GV, et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2008;14:138-143 (Pubitemid 351267268)
35. Khettry U, Keaveny A, Goldar-Najafi A, et al. Liver transplantation for primary sclerosing cholangitis: A long-term clinicopathologic study. Hum Pathol 2003;34:1127-1136 (Pubitemid 37466998)
36. Jeyarajah DR, Netto GJ, Lee SP, et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process? Transplantation 1998 27;66:1300-1306
37. Kugelmas M, Spiegelman P, Osgood MJ, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003;9:727-732
38. Brandsaeter B, Schrumpf E, Bentdal O, et al. Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005;11:1361-1369
39. Charatcharoenwitthaya P, Lindor KD. Recurrence of primary sclerosing cholangitis: What do we learn from several transplant centers? Liver Transpl 2008;14:130-132
40. Penn I. Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 1986;162:603-610
41. Broome U, Lindberg G, Lofberg R. Primary sclerosing cholangitis in ulcerative colitis - a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 1992;102:1877-1880
42. Bleday R, Lee E, Jessurun J, et al. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993;36:908-912
43. Loftus EV Jr, Aguilar HI, Sandborn WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998;27:685-690
44. Leddin D, Hunt R, Champion M, et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol 2004;18:93-99